Zacks Investment Research on MSN

Three genomics stocks worth tracking this year

An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
GEN’s first virtual event of 2026—we present a group of outstanding researchers and thought-leaders to discuss the latest advances and challenges in delivering genetic therapies.
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for ...
The American Society of Gene & Cell Therapy (ASGCT), the leading professional organization for the advancement of cell and gene therapies (CGTs), and the Orphan Therapeutics Accelerator (OTXL), a ...
Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...
Pharmacogenetics and pharmacogenomics are increasingly recognised as playing a pivotal role in the advancement of personalised medicine, especially in the ...
The firm plans to enroll US patients into the trial of GEB-101 in the second quarter, having launched an investigator-initiated trial in China.